{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:02:43Z","timestamp":1784264563935,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81472088"],"award-info":[{"award-number":["81472088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rheumatoid arthritis (RA) is an autoimmune polyarthritis in which synovial fibroblasts (SF) play a major role in cartilage and bone destruction through tumorlike proliferation, migration, and invasion. Nesfatin-1, an 82-amino-acid-long peptide discovered by Oh-I in 2006, is derived from the precursor protein nucleobindin-2 (NUCB2). NUCB2\/nesfatin-1 promotes cell proliferation, migration, and invasion in various tumors. We have previously shown that increased nesfatin-1 levels in the synovium may be associated with disease severity in patients with RA. However, the effect of NUCB2 on the tumorlike transformation of RASF has not yet been reported. The expression of <jats:italic>NUCB2<\/jats:italic> mRNA in the synovium of RA and non-RA patients was further confirmed using three individual datasets from the NCBI GEO database. Gene set enrichment analysis (GSEA) was employed to explore the association between <jats:italic>NUCB2<\/jats:italic> mRNA and RA-related gene signatures or signaling pathways in the GSE77298 dataset. Cell proliferation, migration, and invasion abilities were determined using Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU), wound healing, and transwell assays, respectively. The results showed that the levels of <jats:italic>NUCB2<\/jats:italic> mRNA in the synovium were significantly elevated in patients with RA. Moreover, GSEA showed that high expression of <jats:italic>NUCB2<\/jats:italic> mRNA was related to gene signatures, including those involved in the cell cycle, DNA replication, extracellular matrix\u2013receptor interaction, and focal adhesion. Furthermore, the results of CCK-8 and EdU assays indicated that inhibition of NUCB2 markedly repressed RASF proliferation. Additionally, the results of wound healing and transwell assays demonstrated that inhibition of NUCB2 significantly suppressed the migratory and invasive abilities of RASFs. Our findings are the first to demonstrate that the inhibition of NUCB2 suppresses the proliferation, migration, and invasion of RASFs in vitro.<\/jats:p>","DOI":"10.1186\/s13018-022-03453-2","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T05:02:40Z","timestamp":1672376560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhibition of NUCB2 suppresses the proliferation, migration, and invasion of rheumatoid arthritis synovial fibroblasts from patients with rheumatoid arthritis in vitro"],"prefix":"10.1186","volume":"17","author":[{"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genxiang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juehua","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"3453_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"G Firestein","year":"2003","unstructured":"Firestein G. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature"},{"key":"3453_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar2337","volume":"9","author":"U M\u00fcller-Ladner","year":"2007","unstructured":"M\u00fcller-Ladner U, Ospelt C, Gay S, Distler O, Pap T. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Res Ther. 2007;9:223.","journal-title":"Arthritis Res Ther"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/art.27297","volume":"62","author":"H Perlman","year":"2010","unstructured":"Perlman H, Pope R. The synovial lining micromass system: toward rheumatoid arthritis in a dish? Arthritis Rheum. 2010;62:643\u20136.","journal-title":"Arthritis Rheum"},{"key":"3453_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41232-021-00157-8","volume":"41","author":"H Tsuchiya","year":"2021","unstructured":"Tsuchiya H, Ota M, Fujio K. Multiomics landscape of synovial fibroblasts in rheumatoid arthritis. Inflamm Regen. 2021;41:7.","journal-title":"Inflamm Regen"},{"key":"3453_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein G. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233\u201355.","journal-title":"Immunol Rev"},{"key":"3453_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","volume":"45","author":"L Huber","year":"2006","unstructured":"Huber L, Distler O, Tarner I, Gay R, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford). 2006;45:669\u201375.","journal-title":"Rheumatology (Oxford)"},{"key":"3453_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature05162","volume":"443","author":"S Oh-I","year":"2006","unstructured":"Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709\u201312.","journal-title":"Nature"},{"key":"3453_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.psyneuen.2018.09.037","volume":"100","author":"E Weibert","year":"2019","unstructured":"Weibert E, Hofmann T, Stengel A. Role of nesfatin-1 in anxiety, depression and the response to stress. Psychoneuroendocrinology. 2019;100:58\u201366.","journal-title":"Psychoneuroendocrinology"},{"key":"3453_CR9","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JOE-16-0361","volume":"232","author":"R Dore","year":"2017","unstructured":"Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol. 2017;232:R45\u201365.","journal-title":"J Endocrinol"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.3390\/ijms22158313","volume":"22","author":"A Kmiecik","year":"2021","unstructured":"Kmiecik A, Dzi\u0119giel P, Podhorska-Oko\u0142\u00f3w M. Nucleobindin-2\/nesfatin-1\u2014a new cancer related molecule? Int J Mol Sci. 2021;22:8313.","journal-title":"Int J Mol Sci"},{"key":"3453_CR11","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.3390\/ijms22115687","volume":"22","author":"A Skorupska","year":"2021","unstructured":"Skorupska A, Lenda R, O\u017cyhar A, Bystranowska D. The multifaceted nature of nucleobindin-2 in carcinogenesis. Int J Mol Sci. 2021;22:5687.","journal-title":"Int J Mol Sci"},{"key":"3453_CR12","doi-asserted-by":"publisher","first-page":"31336","DOI":"10.18632\/oncotarget.9140","volume":"7","author":"J Kan","year":"2016","unstructured":"Kan J, Yen M, Wang J, Wu D, Chiu Y, Ho Y, et al. Nesfatin-1\/nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1\/AMPK\/TORC1\/ZEB1 pathways in colon cancer. Oncotarget. 2016;7:31336\u201349.","journal-title":"Oncotarget"},{"key":"3453_CR13","first-page":"3653","volume":"19","author":"R Tao","year":"2020","unstructured":"Tao R, Niu W, Dou P, Ni S, Yu Y, Cai L, et al. Nucleobindin-2 enhances the epithelial-mesenchymal transition in renal cell carcinoma. Oncol Lett. 2020;19:3653\u201364.","journal-title":"Oncol Lett"},{"key":"3453_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1507\/endocrj.EJ15-0490","volume":"63","author":"K Takagi","year":"2016","unstructured":"Takagi K, Miki Y, Tanaka S, Hashimoto C, Watanabe M, Sasano H, et al. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration. Endocr J. 2016;63:287\u201399.","journal-title":"Endocr J"},{"key":"3453_CR15","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.2147\/IJGM.S330099","volume":"14","author":"S Zhang","year":"2021","unstructured":"Zhang S, Rong G, Xu Y, Jing J. Elevated nesfatin-1 level in synovium and synovial fluid is associated with pro-inflammatory cytokines in patients with rheumatoid arthritis. Int J Gen Med. 2021;14:5269\u201378.","journal-title":"Int J Gen Med"},{"key":"3453_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/hum.2015.127","volume":"27","author":"M Broeren","year":"2016","unstructured":"Broeren M, de Vries M, Bennink M, Arntz O, Blom A, Koenders M, et al. Disease-regulated gene therapy with anti-inflammatory interleukin-10 under the control of the CXCL10 promoter for the treatment of rheumatoid arthritis. Hum Gene Ther. 2016;27:244\u201354.","journal-title":"Hum Gene Ther"},{"key":"3453_CR17","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar4526","volume":"16","author":"D Woetzel","year":"2014","unstructured":"Woetzel D, Huber R, Kupfer P, Pohlers D, Pfaff M, Driesch D, et al. Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation. Arthritis Res Ther. 2014;16:R84.","journal-title":"Arthritis Res Ther"},{"key":"3453_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1152\/physiolgenomics.00004.2010","volume":"42A","author":"U Ungethuem","year":"2010","unstructured":"Ungethuem U, Haeupl T, Witt H, Koczan D, Krenn V, Huber H, et al. Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics. 2010;42A:267\u201382.","journal-title":"Physiol Genomics"},{"key":"3453_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M, Paulovich A, Pomeroy S, Golub T, Lander E, Mesirov J. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3453_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41374-021-00636-z","volume":"101","author":"J Tao","year":"2021","unstructured":"Tao J, Lu Z, Su J, Qian X, Zhang Y, Xu Y, Song S, Hang X, Peng X, Chen F. ASIC1a promotes the proliferation of synovial fibroblasts via the ERK\/MAPK pathway. Lab Investig. 2021;101:1353\u201362.","journal-title":"Lab Investig"},{"key":"3453_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7150\/thno.37200","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Qian X, Yang X, Niu R, Song S, Zhu F, Zhu C, Peng X, Chen F. ASIC1a induces synovial inflammation via the Ca\/NFATc3\/RANTES pathway. Theranostics. 2020;10:247\u201364.","journal-title":"Theranostics"},{"key":"3453_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/biom11020325","volume":"11","author":"G Vasileiadis","year":"2021","unstructured":"Vasileiadis G, Lundell A, Zhang Y, Andersson K, Gjertsson I, Rudin A, et al. Adipocytokines in untreated newly diagnosed rheumatoid arthritis: association with circulating chemokines and markers of inflammation. Biomolecules. 2021;11:325.","journal-title":"Biomolecules."},{"key":"3453_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cells10020216","volume":"10","author":"E Neumann","year":"2021","unstructured":"Neumann E, Hasseli R, Ohl S, Lange U, Frommer K, M\u00fcller-Ladner U. Adipokines and autoimmunity in inflammatory arthritis. Cells. 2021;10:216.","journal-title":"Cells."},{"key":"3453_CR24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1136\/ard.2005.046540","volume":"65","author":"M Otero","year":"2006","unstructured":"Otero M, Lago R, Gomez R, Lago F, Dieguez C, G\u00f3mez-Reino J, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:1198\u2013201.","journal-title":"Ann Rheum Dis"},{"key":"3453_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00296-008-0764-8","volume":"29","author":"A Seven","year":"2009","unstructured":"Seven A, G\u00fczel S, Aslan M, Hamuryudan V. Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int. 2009;29:743\u20137.","journal-title":"Rheumatol Int"},{"key":"3453_CR26","first-page":"698","volume":"24","author":"K Migita","year":"2006","unstructured":"Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, et al. The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006;24:698\u2013701.","journal-title":"Clin Exp Rheumatol"},{"key":"3453_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/JIR.S273446","volume":"13","author":"Y Xu","year":"2020","unstructured":"Xu Y, Chen F. Antioxidant, anti-inflammatory and anti-apoptotic activities of nesfatin-1: a review. J Inflamm Res. 2020;13:607\u201317.","journal-title":"J Inflamm Res"},{"key":"3453_CR28","first-page":"53","volume":"64","author":"T Kvlividze","year":"2019","unstructured":"Kvlividze T, Zavodovsky B, Akhverdyan Y, Polyakova Y, Sivordova L, Yakovlev A, Zborovskaya I. Serum nesfatin-1 as a marker of systemic inflammation in rheumatoid arthritis. Klinicheskaia laboratornaia diagnostika. 2019;64:53\u20136.","journal-title":"Klinicheskaia laboratornaia diagnostika"},{"key":"3453_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.peptides.2018.02.002","volume":"102","author":"C Robinson","year":"2018","unstructured":"Robinson C, Tsang L, Solomon A, Woodiwiss A, Gunter S, Mer M, et al. Nesfatin-1 and visfatin expression is associated with reduced atherosclerotic disease risk in patients with rheumatoid arthritis. Peptides. 2018;102:31\u20137.","journal-title":"Peptides"},{"key":"3453_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-9966-32-56","volume":"32","author":"H Zhang","year":"2013","unstructured":"Zhang H, Qi C, Li L, Luo F, Xu Y. Clinical significance of NUCB2 mRNA expression in prostate cancer. J Exp Clin Cancer Res: CR. 2013;32:56.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"3453_CR31","doi-asserted-by":"publisher","first-page":"31336","DOI":"10.18632\/oncotarget.9140","volume":"7","author":"J Kan","year":"2016","unstructured":"Kan J, Yen M, Wang J, Wu D, Chiu Y, Ho Y, Kuo P. Nesfatin-1\/nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1\/AMPK\/TORC1\/ZEB1 pathways in colon cancer. Oncotarget. 2016;7:31336\u201349.","journal-title":"Oncotarget"},{"key":"3453_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1349-7006.2011.02119.x","volume":"103","author":"S Suzuki","year":"2012","unstructured":"Suzuki S, Takagi K, Miki Y, Onodera Y, Akahira J, Ebata A, Ishida T, Watanabe M, Sasano H, Suzuki T. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Cancer Sci. 2012;103:136\u201343.","journal-title":"Cancer Sci"},{"key":"3453_CR33","first-page":"4272064","volume":"2018","author":"G Liu","year":"2018","unstructured":"Liu G, Xu Z, Ma H. Nesfatin-1\/nucleobindin-2 is a potent prognostic marker and enhances cell proliferation. Migr Invasion Bladder Cancer Dis Markers. 2018;2018:4272064.","journal-title":"Migr Invasion Bladder Cancer Dis Markers"},{"key":"3453_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-018-0842-z","volume":"37","author":"D Zhang","year":"2018","unstructured":"Zhang D, Lin J, Chao Y, Zhang L, Jin L, Li N, et al. Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression. J Exp Clin Cancer Res: CR. 2018;37:176.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"3453_CR35","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3892\/or.2016.4558","volume":"35","author":"J Burgos","year":"2016","unstructured":"Burgos J, Iresj\u00f6 B, Smedh U. MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides. Oncol Rep. 2016;35:2425\u201330.","journal-title":"Oncol Rep"},{"key":"3453_CR36","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"D Scott","year":"2010","unstructured":"Scott D, Wolfe F, Huizinga T. Rheumatoid arthritis. Lancet (London, England). 2010;376:1094\u2013108.","journal-title":"Lancet (London, England)"},{"key":"3453_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu J, Thompson C. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20:436\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3453_CR38","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/jcb.27681","volume":"120","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 2019;120:2782\u201390.","journal-title":"J Cell Biochem"},{"key":"3453_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.devcel.2019.03.026","volume":"49","author":"F Kai","year":"2019","unstructured":"Kai F, Drain A, Weaver V. The extracellular matrix modulates the metastatic journey. Dev Cell. 2019;49:332\u201346.","journal-title":"Dev Cell"},{"key":"3453_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/01.RES.0000207408.31270.db","volume":"98","author":"L Romer","year":"2006","unstructured":"Romer L, Birukov K, Garcia J. Focal adhesions: paradigm for a signaling nexus. Circ Res. 2006;98:606\u201316.","journal-title":"Circ Res"},{"key":"3453_CR41","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2147\/OTT.S184560","volume":"12","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yun X, Ruan X, Chi J, Yu Y, Li Y, Zheng X, Gao M. High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion. Onco Targets Ther. 2019;12:1309\u201318.","journal-title":"Onco Targets Ther"},{"key":"3453_CR42","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1210\/en.2007-0701","volume":"148","author":"G Brailoiu","year":"2007","unstructured":"Brailoiu G, Dun S, Brailoiu E, Inan S, Yang J, Chang J, Dun N. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology. 2007;148:5088\u201394.","journal-title":"Endocrinology"},{"key":"3453_CR43","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2009.10.085","volume":"390","author":"Y Iwasaki","year":"2009","unstructured":"Iwasaki Y, Nakabayashi H, Kakei M, Shimizu H, Mori M, Yada T. Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun. 2009;390:958\u201362.","journal-title":"Biochem Biophys Res Commun"},{"key":"3453_CR44","doi-asserted-by":"publisher","first-page":"e50918","DOI":"10.1371\/journal.pone.0050918","volume":"7","author":"E Ishida","year":"2012","unstructured":"Ishida E, Hashimoto K, Shimizu H, Okada S, Satoh T, Kato I, Yamada M, Mori M. Nesfatin-1 induces the phosphorylation levels of cAMP response element-binding protein for intracellular signaling in a neural cell line. PLoS ONE. 2012;7:e50918.","journal-title":"PLoS ONE"},{"key":"3453_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrc2171","volume":"7","author":"G Monteith","year":"2007","unstructured":"Monteith G, McAndrew D, Faddy H, Roberts-Thomson S. Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer. 2007;7:519\u201330.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03453-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T09:16:27Z","timestamp":1672650987000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03453-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03453-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Anhui Medical University. All participants understood the purpose of this study and provided written informed consent prior to enrollment in this study, in accordance with the principles expressed in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"574"}}